Journal of Vascular Surgery
Volume 53, Issue 1 , Pages 156-164 , January 2011

The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine

  • Zhiwei Xu, PhD

      Affiliations

    • Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Peoples Republic of China
    • ,
  • Taohua Lan, MD

      Affiliations

    • Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Peoples Republic of China
    • ,
  • Weikang Wu, MD

      Affiliations

    • Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Peoples Republic of China
    • Corresponding Author InformationCorrespondence: Weikang Wu, Master of Medicine, Department of Pathophysiology, ZhongShan Medical College, Sun Yat-sen University, 74 Zhongshan Second Rd, Guangzhou 510080, PR China
    • ,
  • Yiling Wu, PhD

      Affiliations

    • Yiling Pharmaceutical Research Institute, Shijiazhuang, Peoples Republic of China

Received 9 March 2010 ,Accepted 27 June 2010.

References 

  1. Lü JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009;7:293–302
  2. Arushanian EB. Therapeutic potential of ginseng root preparations in treating diabetes mellitus. Eksp Klin Farmakol. 2009;72:52–56
  3. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol. 1996;23:728–732
  4. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit. 2004;10:187–192
  5. Sun J, Tan H, Cheng C, Wu W, Wu Y, Sun H. Hyperhomocysteinemia induces endothelial dysfunction and aggravates microcirculation dysfunction and microthrombosis. CJPP. 2007;23:2336–2340
  6. Lan T, Tan H, Wu W, Wu Y, Sun J, Han Y, et al. Effects of the typical herbal medicine for collaterals deoppilation on rats with endothelial dysfunction and the comparison with Tongxinluo. The 3rd Word Integrative Medicine Congress Abstracts. 2007;3:184–185
  7. García EA, Korbonits M. Ghrelin and cardiovascular health. Curr Opin Pharmacol. 2006;6:142–147
  8. Iglesias MJ, Piñeiro R, Blanco M, Gallego R, Diéguez C, Gualillo O, et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res. 2004;62:481–488
  9. Hedayati N, Annambhotla S, Jiang J, Wang X, Chai H, Lin PH, et al. Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg. 2009;49:199–207
  10. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 2005;41:861–868
  11. Ungvari Z, Pacher P, Rischak K. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 1999;19:1899–1904
  12. Wang C, Zhang Y, Yang Q, Yang Y, Gu Y, Wang M, et al. A novel cultured tissue model of rat aorta: VSMC proliferation mechanism in relationship to atherosclerosis. Exp Mol Pathol. 2007;83:453–458
  13. Arun KH, Kaul CL, Ramarao P. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats. Cardiovasc Res. 2005;65:374–386
  14. White CN, Hamilton EJ, Garcia A, Wang D, Chia KK, Figtree GA, et al. Opposing effects of coupled and uncoupled NOS activity on the Na+-K+ pump in cardiac myocytes. Am J Physiol Cell Physiol. 2008;294:572–578
  15. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature. 1999;402:656–660
  16. Weiss N, Keller C, Hoffmann U, Loscalzo J. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Me. 2002;7:227–239
  17. Chen C, Conklin BS, Ren Z, Zhong DS. Homocysteine decreases endothelium-dependent vaso-relaxation in porcine arteries. J Surg Res. 2002;102:22–30
  18. Jiang X, Yang F, Tan H, Liao D, Bryan RM, Randhawa JK, et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol. 2005;25:2515–2521
  19. Chow K, Cheung F, Lao TT. Effect of homocysteine on the production of nitric oxide in endothelial cells. O K Clin Ex p Pharmacol Physiol. 1999;26:817–818
  20. Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis. 2002;161:233–242
  21. Kim JH, Cho SY, Kang CW, Yoon IS, Lee JH, Jeong SM, et al. Ginseng saponins diminish adverse vascular effects associated with chronic methronine-induced hyperhomocysteinemia. Biol Pharm Bull. 2006;29:2425–2431
  22. Li Z, Niwa Y, Sakamoto S, Shono M, Chen X, Nakaya Y. Induction of inducible nitric oxide synthase by ginsenosides in cultured porcine endothelial cells. Life Sci. 2000;67:2983–2989
  23. Li Z, Chen X, Niwa Y, Sakamoto S, Nakaya Y. Involvement of Ca2+ -activated K+ channels in ginsenosides-induced aortic relaxation in rats. J Cardiovasc Pharmacol. 2001;37:41–47
  24. Huimei Xie, Ge Hu, Zhanwei Suo. Effect of ginsenoside Rb1 and astragalus polysaccharide on the excretion of NO, IL-6 and TNF-α in micro-vascular endothelial cells. Acta Vet Zool Sin. 2006;37:903–907
  25. Yiling Wu, Yanning Li, Jinsheng Qi, Zhenhua Jia, Kun Liu. Effect of ginsenoside on gene expression profile associated with blood vessel endothelium injure of rats with deficiency of vital energy. Nat Prod Res Dev. 2007;19:973–977
  26. Chai H, Dong Y, Wang X, Zhou W. Ginsenoside Rb1 attenuates homocysteine augmented guidewire injury-induced intimal hyperplasia in mice. J Surg Res. 2009;157:193–198
  27. Ohashi R, Yan S, Mu H, Chai H, Yao Q, Lin PH, et al. Effects of homocyteine and ginsenoside Rb1 on endothelial proliferation and superoxide anion production. J Surg Res. 2006;133:89–94
  28. Papotti M, Ghe C, Cassoni P, Catapano F, Deghenghi R, Ghigo E, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab. 2000;85:3803–3807
  29. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T, et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun. 2003;310:830–835
  30. Katugampola SD, Maguire JJ, Kuc RE, Wiley KE, Davenport AP. Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. Can J Physiol Pharmacol. 2002;80:369–374
  31. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol. 2002;136:1146–1152
  32. Chang L, Zhao J, Li GZ, Geng B, Pan CS, Qi YF, et al. Ghrelin protects myocardium from isoproterenol-induced injury in rats. Acta Pharmacol Sin. 2004;25:1131–1137
  33. Li GZ, Jiang W, Zhao J, Pan CS, Cao J, Tang CS, et al. Ghrelin blunted vascular calcification in vivo and in vitro in rats. Regul Pept. 2005;129:167–176
  34. Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001;104:2034–2038
  35. Xu Z, Wu W, Zhang X, Liu G. Endogenous ghrelin increases in ADR-induced heart failure rats. J Endocrinol Invest. 2007;30:117–125
  36. Xu Z, Lin S, Wu W, Tan H, Wang Z, Cheng C, et al. Growth hormone releasing peptide (ghrelin) inhibits doxorubicin induced cardiotoxicity through mitochondria mediated pathways. Toxicology. 2008;247:133–138
  37. Iglesias MJ, Piñeiro R, Blanco M, Gallego R, Diéguez C, Gualillo O, et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res. 2004;62:481–488

 This work was supported by the National Key Basic Research and Development Project of China (973 Project, No. 2005CB523305), and the 44th China's Post-doctoral Science Fund (No. 20080440808).

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)01676-9

doi: 10.1016/j.jvs.2010.06.170

Journal of Vascular Surgery
Volume 53, Issue 1 , Pages 156-164 , January 2011

Article Tools

* Image Usage & Resolution